The study aim was to describe the emergence of carbapenem Antimicrobial susceptibility was determined by disk diffusion [6] for: amikacin, gentamicin, tobramycin, ampicillin-sulbactam, cefepime, ceftazidime, ciprofloxacin, imipenem, meropenem, minocycline, tetracycline, piperacillin-tazobactam and trimethoprim-sulphamethoxazole. Minimum inhibitory concentrations (MICs) of cefepime, imipenem, meropenem and tigecycline were defined by Etest following the manufacturer's instructions (bioM erieux, Solna, Sweden). Colistin MICs were determined by broth microdilution [7] . Susceptibility to all agents was interpreted as recommended by CLSI [8], except for tigecycline, interpreted as proposed by the US Food and Drug Administration (FDA) for Enterobacteriaceae. Isolates were classified as multidrug-resistant (MDR) or extensively drug-resistant (XDR) [9] . Metallo-b-lactamase production was screened by a double-disk test [10] . The following carbapenemase encoding genes were investigated by PCR: bla OXA-23-like , bla OXA-24-like , bla OXA-51-like , bla OXA-58-like , bla OXA-143 , bla KPC , bla NDM , bla GIM-1 , bla IMP-type , bla SIM-1 , bla SPM-1 , bla VIM-type , bla CTX-M-1 , bla CTX-M-2 , bla CTX-M-8 , bla CTX-M-9 and bla CTX-M-25 [11] [12] [13] [14] [15] . Isolates were typed by pulsed-field gel electrophoresis (PFGE) [16] and included within a pulsotype if band profiles had 5 differences. UO and IP MLST schemes were performed [17, 18] . CCs were formed by STs with five or more identical alleles by goeBURST (goeburst.phyloviz.net). STs and CCs are here referred by the UO/IP scheme.
Acinetobacter baumannii has become increasingly recognized as a cause of multidrug-resistant central nervous system infections [1] . A. baumannii clones are classified by multilocus sequence typing (MLST) by protocols hosted at Institut Pasteur (IP, www.pasteur.fr) and the University of Oxford (UO, www. pubmlst.org), and grouped into clonal complexes (CCs). Typing an isolate by both schemes is useful as there is no link between IP and UO databases. To date, little is known about the population structure of A. baumannii from cases of meningitis worldwide [2] . In 1996, a hospital-based activesurveillance for bacterial meningitis was established at Hospital Couto Maia, a state infectious disease reference hospital in Salvador, Brazil [3] . The main purpose of this system was to investigate classical pathogens Haemophilus influenzae, Neisseria meningitidis and Streptococcus pneumoniae. Non-classical agents were also sought because all CSF specimens from public hospitals in the city are processed at this hospital. The aim of the present study was to describe the emergence of carbapenem resistance in Acinetobacter spp and the distribution of A. baumannii CCs in isolates recovered from meningitis in this system. A case of culture-proven bacterial meningitis was a patient with typical symptoms and Acinetobacter sp isolated from CSF. From 2002 to 2008, 57 cases of hospital-acquired Acinetobacter sp meningitis were detected; 35 isolates (one per patient) were saved. Species were identified by sequence analysis of 350-bp rpoB gene fragments [4] and defined by at least 97% similarity with one in a set of reference strains and by BLAST [5] .
Antimicrobial susceptibility was determined by disk diffusion [6] for: amikacin, gentamicin, tobramycin, ampicillin-sulbactam, cefepime, ceftazidime, ciprofloxacin, imipenem, meropenem, minocycline, tetracycline, piperacillin-tazobactam and trimethoprim-sulphamethoxazole. Minimum inhibitory concentrations (MICs) of cefepime, imipenem, meropenem and tigecycline were defined by Etest following the manufacturer's instructions (bioM erieux, Solna, Sweden). Colistin MICs were determined by broth microdilution [7] . Susceptibility to all agents was interpreted as recommended by CLSI [8] , except for tigecycline, interpreted as proposed by the US Food and Drug Administration (FDA) for Enterobacteriaceae. Isolates were classified as multidrug-resistant (MDR) or extensively drug-resistant (XDR) [9] . Metallo-b-lactamase production was screened by a double-disk test [10] . The following carbapenemase encoding genes were investigated by PCR: bla OXA-23-like , bla OXA-24-like , bla OXA-51-like , bla OXA-58-like , bla OXA-143 , bla KPC , bla NDM , bla GIM-1 , bla IMP-type , bla SIM-1 ,
and bla CTX-M-25 [11] [12] [13] [14] [15] . Isolates were typed by pulsed-field gel electrophoresis (PFGE) [16] and included within a pulsotype if band profiles had 5 differences. UO and IP MLST schemes were performed [17, 18] . CCs were formed by STs with five or more identical alleles by goeBURST (goeburst.phyloviz.net). STs and CCs are here referred by the UO/IP scheme. (Table 1) . STs formed four CCs by UO, and three by the IP scheme, unrelated to international clones I, II and III. ST164 by the IP scheme was not assigned to a CC because this is a double locus variant (DLV) of just one other ST. Each of the seven CCs was isolated over more than 20 months during the 6 years of surveillance (Fig. 1) . CC113/79 included the colistin-resistant isolate (ST237/79). Although 22 of the 57 cases detected in the surveillance system could not have the species determined, we believe all these cases were indeed caused by the genus Acinetobacter because such identification is simple. No further data about Acinetobacter infections in the study hospital are available; however, these infections are likely to be part of hospital dissemination of this pathogen, previously noted in Brazil [19] .
Carbapenem resistance was first detected by the system in 2006 and increased over time to affect 16 of the 31 study A. baumannii isolates, associated with the presence of the bla OXA-23 gene. Alarmingly, 14 of A. baumannii isolates were XDR. High susceptibility to colistin, minocycline and tigecycline was observed. Colistin has been recommended for meningitis caused by carbapenem-resistant A. baumannii [20] , but resistance should become increasingly frequent. Use of tigecycline has been described as effective in a few case reports [20] ; however, the pharmacodynamic profile of this drug does not seem adequate for this purpose [20] .
CC113/79, CC235/162 and CC103/15 were important causes of meningitis in the present study and prone to develop resistance to multiple agents. Except for the ATCC 17978 strain, no other isolate from patients with meningitis could be related to the CCs of the present study. This finding suggests that meningitis is not caused preferentially by isolates with a specific tropism for the central nervous system, but by clones circulating in hospitals.
